Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 24, 2023 - Issue 5-6
Submit an article Journal homepage
2,708
Views
3
CrossRef citations to date
0
Altmetric
Genetics

Clinical testing panels for ALS: global distribution, consistency, and challenges

Allison A. Dilliott1 Department of Neurology and Neurosurgery, McGill University, Montreal, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3863-9304View further author information
ORCID Icon,
Ahmad Al Nasser2 Schulich School of Medicine and Dentistry, Western University, London, CanadaView further author information
,
Marwa Elnagheeb3 Department of Genetics, University of North Carolina, Chapel Hill, NC, USAView further author information
,
Jennifer Fifita4 Centre for MND Research, Macquarie Medical School, Macquarie University, Sydney, AustraliaView further author information
,
Lyndal Henden4 Centre for MND Research, Macquarie Medical School, Macquarie University, Sydney, AustraliaView further author information
,
Ingrid M. Keseler5 Department of Biomedical Data Science, Stanford University, Stanford, CA, USAView further author information
,
Steven Lenz6 PreventionGenetics, Marshfield, WI, USAView further author information
,
Heather Marriott7 Department of Basic and Clinical Neuroscience, King’s College London, London, UKView further author information
,
Emily Mccann4 Centre for MND Research, Macquarie Medical School, Macquarie University, Sydney, AustraliaView further author information
,
Maysen Mesaros8 Medical University of South Carolina, Charleston, SC, USAView further author information
,
Sarah Opie-Martin7 Department of Basic and Clinical Neuroscience, King’s College London, London, UKORCID Iconhttps://orcid.org/0000-0003-0951-8589View further author information
ORCID Icon,
Emma Owens3 Department of Genetics, University of North Carolina, Chapel Hill, NC, USAView further author information
,
Brooke Palus3 Department of Genetics, University of North Carolina, Chapel Hill, NC, USAView further author information
,
Justyne Ross3 Department of Genetics, University of North Carolina, Chapel Hill, NC, USAView further author information
,
Zhanjun Wang9 Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Hannah White10 Invitae, San Francisco, CA, USAView further author information
,
Ammar Al-Chalabi7 Department of Basic and Clinical Neuroscience, King’s College London, London, UKORCID Iconhttps://orcid.org/0000-0002-4924-7712View further author information
ORCID Icon,
Peter M. Andersen11 Department of Clinical Sciences, Neurosciences, Umeå University, Umeå, SwedenView further author information
,
Michael Benatar12 Department of Neurology, University of Miami, Miami, FL, USAORCID Iconhttps://orcid.org/0000-0003-4241-5135View further author information
ORCID Icon,
Ian Blair4 Centre for MND Research, Macquarie Medical School, Macquarie University, Sydney, AustraliaView further author information
,
Johnathan Cooper-Knock13 Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UKView further author information
,
Elizabeth A. Harrington14 Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York City, NY, USAView further author information
,
Jeannine Heckmann15 Division of Neurology, University of Cape Town, Cape Town, South AfricaView further author information
,
John Landers16 Department of Neurology, University of Massachusetts Amherst, Amherst, MA, USAView further author information
,
Cristiane Moreno17 Department of Neurology, University of Sao Paulo, Sao Paulo, BrazilView further author information
,
Melissa Nel15 Division of Neurology, University of Cape Town, Cape Town, South AfricaView further author information
,
Evadnie Rampersaud18 Center for Applied Bioinformatics, St. Jude’s Children’s Hospital, Memphis, TN, USAView further author information
,
Jennifer Roggenbuck19 Department of Internal Medicine, Ohio State University, Columbus, OH, USAView further author information
,
Guy Rouleau1 Department of Neurology and Neurosurgery, McGill University, Montreal, Canada;20 Department of Genetics, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada;21 Montreal Neurological Institute and Hospital, McGill University, Montreal, CanadaView further author information
,
Bryan Traynor22 Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USAView further author information
,
Marka Van Blitterswijk23 Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Wouter Van Rheenen24 Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht, The Netherlands, andView further author information
,
Jan Veldink24 Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht, The Netherlands, andView further author information
,
Jochen Weishaupt25 Department of Neurology, Heidelberg University, Heidelberg, GermanyView further author information
,
Luke Drury6 PreventionGenetics, Marshfield, WI, USAView further author information
,
Matthew B. Harms14 Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York City, NY, USAView further author information
,
Sali M. K. Farhan20 Department of Genetics, Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada;21 Montreal Neurological Institute and Hospital, McGill University, Montreal, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5936-0957View further author information
ORCID Icon & On behalf of the Amyotrophic lateral sclerosis spectrum disorders Gene Curation Expert Panel show all
Pages 420-435 | Received 28 Sep 2022, Accepted 22 Jan 2023, Published online: 10 Mar 2023

References

  • Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci. 2019;13:1310.
  • Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, ITALSGEN Consortium, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323–30.
  • Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11:232–40.
  • Umoh ME, Fournier C, Li Y, Polak M, Shaw L, Landers JE, et al. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology 2016;87:1024–30.
  • Singh N, Ray S, Srivastava A. Clinical Mimickers of Amyotrophic Lateral Sclerosis-Conditions We Cannot Afford to Miss. Ann Indian Acad Neurol. 2018;21:173–8.
  • Richards D, Morren JA, Pioro EP. Time to Diagnosis and Factors Affecting Diagnostic Delay in Amyotrophic Lateral Sclerosis. In: Araki T, ed. Amyotrophic Lateral Sclerosis. Brisbane, AU: Exon Publications. 2021.
  • Dharmadasa T, Scaber J, Edmond E, Marsden R, Thompson A, Talbot K, et al. Genetic testing in motor neurone disease. Pract Neurol. 2022;22:107–16.
  • Salmon K, Anoja N, Breiner A, Chum M, Dionne A, Dupre N, et al. Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practices. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:305–12.
  • Shepheard SR, Parker MD, Cooper-Knock J, Verber NS, Tuddenham L, Heath P, et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021;92:510–8.
  • Chio A, Battistini S, Calvo A, Caponnetto C, Conforti FL, Corbo M, ITALSGEN Consortium, et al. Genetic counselling in ALS: facts, uncertainties and clinical suggestions. J Neurol Neurosurg Psychiatry. 2014;85:478–85.
  • Roggenbuck J, Quick A, Kolb SJ. Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians. Genet Med. 2017;19:267–74.
  • Benatar M, Wuu J, Andersen PM, Bucelli RC, Andrews JA, Otto M, et al. Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study. Neurotherapeutics 2022;19:1248–58.
  • Vajda A, McLaughlin RL, Heverin M, Thorpe O, Abrahams S, Al-Chalabi A, et al. Genetic testing in ALS: A survey of current practices. Neurology 2017;88:991–9.
  • Chen YP, Yu SH, Wei QQ, Cao B, Gu XJ, Chen XP, et al. Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population. J Med Genet. 2022;59:840–9.
  • Klepek H, Goutman SA, Quick A, Kolb SJ, Roggenbuck J. Variable reporting of C9orf72 and a high rate of uncertain results in ALS genetic testing. Neurol Genet. 2019;5:e301.
  • Rubinstein WS, Maglott DR, Lee JM, Kattman BL, Malheiro AJ, Ovetsky M, et al. The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency. Nucleic Acids Res. 2013;41:(Database issue):D925–35.
  • Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:(Database issue):D980–5.
  • Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J, et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 2020;48:D835–D844.
  • Strande NT, Riggs ER, Buchanan AH, Ceyhan-Birsoy O, DiStefano M, Dwight SS, et al. Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource. Am J Hum Genet. 2017;100:895–906.
  • Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, FALS Sequencing Consortium, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436–41.
  • Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, SLAGEN Consortium, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48:1037–42.
  • Dekker AM, Diekstra FP, Pulit SL, Tazelaar GHP, van der Spek RA, van Rheenen W, et al. Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis. Sci Rep. 2019;9:5931.
  • Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, et al. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci Transl Med 2017;9:eaad9157.
  • Teyssou E, Muratet F, Amador MD, Ferrien M, Lautrette G, Machat S, et al. Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis. Neurobiol Aging 2021;99:102 e11–e20.
  • Sainouchi M, Hatano Y, Tada M, Ishihara T, Ando S, Kato T, et al. A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features. Acta Neuropathol Commun. 2021;9:106.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.